Quanterix (NASDAQ: QTRX)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-04 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.610 | -0.490 | 0.1200 | ||||
REV | 28.780M | 29.552M | 772.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Quanterix (NASDAQ: QTRX) through any online brokerage.
Other companies in Quanterix’s space includes: Medpace Hldgs (NASDAQ:MEDP), 10x Genomics (NASDAQ:TXG), Codexis (NASDAQ:CDXS), Olink Holding (NASDAQ:OLK) and SomaLogic (NASDAQ:SLGC).
The latest price target for Quanterix (NASDAQ: QTRX) was reported by Goldman Sachs on Wednesday, May 11, 2022. The analyst firm set a price target for 30.00 expecting QTRX to rise to within 12 months (a possible 78.68% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Quanterix (NASDAQ: QTRX) is $16.79 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Quanterix.
Quanterix’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Quanterix.
Quanterix is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.